Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.60) by 6.67 percent. This is a 6.67 percent increase over losses of $(0.60) per share from the same period last year.
Susquehanna Maintains Positive on Halliburton, Raises Price Target to $57
Susquehanna analyst Charles Minervino maintains Halliburton (NYSE:HAL) with a Positive and raises the price target from $51 to $57.